UK organisations allocate £9m to r&d

Published: 13-Sep-2011
Research & Development Finance

For projects focused on nanoscale technology enabled solutions for the healthcare sector


The UK’s Technology Strategy Board, in partnership with the Engineering and Physical Sciences Research Council (EPSRC), have jointly allocated up to £9m to support business-led collaborative research projects focused on nanoscale technology enabled solutions for the healthcare sector, specifically in the areas of diagnostics and targeted therapeutics.

The Technology Strategy Board will invest up to £3m to support involvement by businesses, while EPSRC will invest up to £6m to support participation by academic institutions.

The organisations are looking for projects where nanoscale technologies are at the heart of the innovation.

The Nanoscale Technology Enabled Healthcare competition opens on 1 November and applications must be received by 13 December.

  • Companies:
  • EPSRC Engineering and Physical Sciences Research Council
  • Innovate UK
See more

You may also like

Manufacturing

Innovate UK awards Stablepharma grant to advance fridge-free vaccine

Read more
Innovate UK has awarded Stablepharma a grant to advance its lead candidate SPVX02, a fridge-free vaccine for the prevention of Tetanus and Diphtheria

Trending Articles

  1. LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
  2. Fasenra for EGPA: addressing unmet needs Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
  3. Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
  4. Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Innovate UK awards Stablepharma grant to advance fridge-free vaccine

Innovate UK has awarded Stablepharma a grant to advance its lead candidate SPVX02, a fridge-free vaccine for the prevention of Tetanus and Diphtheria
Research & Development

Intellegens secures $2m to support research of oligonucleotide therapeutic manufacture

In collaboration with CPI, Intellegens has secured a grant from Innovate UK to fund a two year project to augment technology that will assist productivity and yields of oligonucleotide therapeutic manufacture
Finance

Start-up receives Innovate UK funding for intraocular lens implant

Cataract is the most common cause of treatable blindness worldwide and is treated with surgery, however there is risk of postoperative inflammation
Finance

Innovate UK funds biologics manufacturing consortium

This project aims to address challenges faced in the pharmaceutical industry by increasing flexibility and sustainability, and reducing batch failures
Finance

Ingenza receives grant from Eureka and Innovate UK

The grant will support Ingenza as it aims to build a commercially viable <i>P. putida</i> bio-manufacturing pipeline
Research & Development

Turntable-like catalytic reactor wins Innovate funding

The Spinning Disc Mesh Reactor developed by Bath chemical engineers aims to make pharmaceutical production safer and more sustainable
Ingredients

Research partnership removes bottleneck from AAV development

CPI, Cobra Biologics and GE Healthcare Life Sciences have developed a scalable, cost-effective purification process for adeno-associated viruses
Subscribe now